75 results
8-K/A
ALGS
Aligos Therapeutics Inc
24 Jun 21
Departure of Directors or Certain Officers
5:03pm
of directors (the “Board”).
On June 22, 2021, the Board appointed James Scopa to the Audit Committee of the Board (the “Audit Committee”). The Board … determined that Mr. Scopa (i) is independent as defined in Listing Rule 5605 of The Nasdaq Stock Market LLC (“Nasdaq”) for purposes of serving on the Audit
DEF 14A
ALGS
Aligos Therapeutics Inc
27 Apr 21
Definitive proxy
4:15pm
, by the Audit Committee of the Company’s Board of Directors, of Ernst & Young LLP, as the independent registered public accounting firm of the Company …
Principal Accountant Fees and Services
Pre-Approval Policies and Procedures
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CORPORATE GOVERNANCE
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
are elected;
To ratify the appointment, by the Audit Committee of the Company’s Board of Directors, of Ernst & Young LLP, as the independent registered public … OF AUTHORIZED SHARES OF VOTING COMMON STOCK FROM 300,000,000 TO 500,000,000
REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
CORPORATE GOVERNANCE
S-1/A
EX-10.11
vo5kmow0t8
9 Oct 20
IPO registration (amended)
5:26pm
10-K
EX-31.2
jahp s7ntx
23 Mar 21
Annual report
4:26pm
DEFA14A
h4erexi0
28 Apr 23
Additional proxy soliciting materials
4:55pm
DEFA14A
xwerio5a
29 Apr 22
Additional proxy soliciting materials
4:39pm
10-Q
EX-31.2
li11 ulf44
25 Nov 20
Quarterly report
5:21pm
10-K
EX-31.1
vob9x0g
23 Mar 21
Annual report
4:26pm